Citius Oncology secures up to $36.5 million in debt and equity capital led by Avenue Capital, advancing LYMPHIR® commercialization efforts.
Amount Raised
$36.5 Million
Round Type
Venture
CranfordBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalBiopharmaInvestors
Description
Citius Oncology, Inc. has entered a senior secured term loan credit facility with Avenue Capital Group for up to $25 million. An additional $11.5 million is expected from the exercise of outstanding warrants. These funds support the ongoing commercialization of LYMPHIR®, enhancing financial flexibility
Quick answer
Citius Oncology raised $36.5 Million in a funding round, dated May 6, 2026. Investors: Avenue Capital Group and Avenue Venture Opportunities Fund II, L.P. Citius Oncology is based in Cranford, New Jersey, United States.
- How much did Citius Oncology raise?
- Citius Oncology raised $36.5 Million in a funding round on May 6, 2026.
- Who invested in Citius Oncology?
- Avenue Capital Group and Avenue Venture Opportunities Fund II, L.P. are named as investors in this round.
- What does Citius Oncology do?
- Citius Oncology, Inc. is a Delaware-based clinical-stage biopharmaceutical company focused on developing innovative therapies for the treatment of cancer.
- Where is Citius Oncology based and how big is it?
- Citius Oncology is based in Cranford, New Jersey, United States. Fundz records about 19 employees.
- Who are the decision-makers at Citius Oncology?
- Fundz holds 2 contacts at Citius Oncology, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Citius Oncology that raised within 45 days of this round, from Fundz verified event records.
- Windward Bio raised $165M (Funding Round) on May 5, 2026.
- Lighthouse Pharmaceuticals raised $15M (Series A) on April 22, 2026.
- Racura Oncology raised $34M (Funding Round) on June 17, 2026.
- Gate2Brain raised $8.1M on June 16, 2026.
- Edesa Biotech raised $3.5M on June 16, 2026.
- Ingenix raised $15M (Seed) on June 3, 2026.
Who to call at Citius Oncology, and when
A new round usually means Citius Oncology is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Citius Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Citius Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Citius Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Citius Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Citius Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.